在结直肠癌研究中,CRISPR/Cas9是一个强大的工具
Yang Hu1, Liang Liu2, Qi Jiang3
1Department of Gastroenterology, The First People's Hospital of Jiande, Hangzhou, 311600, China.
Journal of experimental & clinical cancer research : CR
|November 23, 2023
概括
集群调节间隔短平行体重复/CRISPR相关核酶9 (CRISPR/Cas9) 系统加速结直肠癌 (CRC) 研究,有助于基因疗法和药物开发. 解决非目标效应对于其在CRC治疗中的临床应用至关重要.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 结肠直肠癌 (CRC) 是全球普遍存在的恶性瘤,具有重大健康风险.
- 由细菌适应性免疫产生的集群调节间隔短平行体重复/CRISPR相关核酶9 (CRISPR/Cas9) 系统提供了精确的基因组编辑能力.
研究的目的:
- 审查CRISPR/Cas9系统在结直肠癌研究和治疗中的机制和各种应用.
- 突出CRISPR/Cas9在推进CRC治疗策略方面的潜力,包括基因疗法和药物开发.
主要方法:
- 文献综述侧重于CRISPR/Cas9在CRC中的应用.
- 分析CRISPR/Cas9在研究瘤基因,瘤抑制基因和抗药性方面的作用.
- 在小鼠模型构建和全基因组查中检查CRISPR/Cas9.
主要成果:
- 克里斯普尔/Cas9加速了对CRC的研究,使得对遗传因素的详细研究和治疗方法的开发成为可能.
- 该系统为CRC基因疗法提供了向基因淘汰和分子向药物输送.
- 使用CRISPR/Cas9进行全基因组图书馆选,已经确定了CRC中的新目标.
结论:
- 该CRISPR/Cas9系统为推进结直肠癌研究和开发创新的治疗策略提供了一个强大的工具.
- 需要进一步的研究来克服诸如非目标效应等挑战,以充分实现CRISPR/Cas9在CRC治疗中的临床潜力.
- 系统和深入地利用CRISPR/Cas9对于将其转化为治疗CRC的临床实践至关重要.
更多相关视频
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
5.9K
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
11.2K
相关概念视频
CRISPR
51.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.8K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
